Yokukansan Increases 5-HT1A Receptors in the Prefrontal Cortex and Enhances 5-HT1A Receptor Agonist-Induced Behavioral Responses in Socially Isolated Mice

The traditional Japanese medicine yokukansan has an anxiolytic effect, which occurs after repeated administration. In this study, to investigate the underlying mechanisms, we examined the effects of repeated yokukansan administration on serotonin 1A (5-HT1A) receptor density and affinity and its expression at both mRNA and protein levels in the prefrontal cortex (PFC) of socially isolated mice. Moreover, we examined the effects of yokukansan on a 5-HT1A receptor-mediated behavioral response. Male mice were subjected to social isolation stress for 6 weeks and simultaneously treated with yokukansan. Thereafter, the density and affinity of 5-HT1A receptors were analyzed by a receptor-binding assay. Levels of 5-HT1A receptor protein and mRNA were also measured. Furthermore, (±)-8-hydroxy-2-(dipropylamino)tetralin hydrobromide (8-OH-DPAT; a 5-HT1A receptor agonist) was injected intraperitoneally, and rearing behavior was examined. Social isolation stress alone did not affect 5-HT1A receptor density or affinity. However, yokukansan significantly increased receptor density and decreased affinity concomitant with unchanged protein and mRNA levels. Yokukansan also enhanced the 8-OH-DPAT-induced decrease in rearing behavior. These results suggest that yokukansan increases 5-HT1A receptors in the PFC of socially isolated mice and enhances their function, which might underlie its anxiolytic effects.

[1]  Y. Kase,et al.  Specific binding and characteristics of geissoschizine methyl ether, an indole alkaloid of Uncaria Hook, in the rat brain. , 2014, Journal of ethnopharmacology.

[2]  N. K. Popova,et al.  Interplay between Serotonin 5‐HT1A and 5‐HT7 Receptors in Depressive Disorders , 2014, CNS neuroscience & therapeutics.

[3]  K. Fuxe,et al.  Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of β-arrestin2. , 2013, Biochemical and biophysical research communications.

[4]  N. Muma,et al.  Estradiol potentiates 8-OH-DPAT-induced sumoylation of 5-HT1A receptor: Characterization and subcellular distribution of sumoylated 5-HT1A receptors , 2013, Psychoneuroendocrinology.

[5]  H. Shoji,et al.  Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats. , 2013, Journal of ethnopharmacology.

[6]  N. Hirokawa,et al.  A molecular motor, KIF13A, controls anxiety by transporting the serotonin type 1A receptor. , 2013, Cell reports.

[7]  Taro Kishi,et al.  Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta‐analysis of randomized controlled trials , 2013, Human psychopharmacology.

[8]  Yu Ohmura,et al.  Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. , 2012, Journal of ethnopharmacology.

[9]  P. Heusler,et al.  μ-Opioid and 5-HT1A receptors heterodimerize and show signalling crosstalk via G protein and MAP-kinase pathways. , 2012, Cellular signalling.

[10]  Daria Guseva,et al.  Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking , 2012, Journal of Cell Science.

[11]  A. Nishi,et al.  Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin1A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan , 2012, Neuroscience.

[12]  A. Nishi,et al.  The Blood–Brain Barrier Permeability of Geissoschizine Methyl Ether in Uncaria Hook, a Galenical Constituent of the Traditional Japanese Medicine Yokukansan , 2011, Cellular and Molecular Neurobiology.

[13]  K. Takeuchi,et al.  Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  Takahiro A. Kato,et al.  Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease , 2009, Progress in Neuro-psychopharmacology and Biological Psychiatry.

[15]  S. Barrondo,et al.  Allosteric modulation of 5-HT1A receptors by zinc: Binding studies , 2009, Neuropharmacology.

[16]  D. Richter,et al.  Localization of the Mouse 5-Hydroxytryptamine1A Receptor in Lipid Microdomains Depends on Its Palmitoylation and Is Involved in Receptor-Mediated Signaling , 2007, Molecular Pharmacology.

[17]  Z. Wasylewski,et al.  Fluorescence studies of homooligomerization of adenosine A2A and serotonin 5-HT1A receptors reveal the specificity of receptor interactions in the plasma membrane. , 2007, Pharmacological reports : PR.

[18]  R. Veh,et al.  Mice over-expressing the 5-HT1A receptor in cortex and dentate gyrus display exaggerated locomotor and hypothermic response to 8-OH-DPAT , 2006, Behavioural Brain Research.

[19]  Sung-Cheng Huang,et al.  Serotonin 1A receptors in the living brain of Alzheimer's disease patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Baba,et al.  Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex , 2003, Neuropharmacology.

[21]  D. Ciraulo Neuropsychopharmacology: The Fifth Generation of Progress , 2003 .

[22]  M. Esiri,et al.  Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease , 2003, Brain Research.

[23]  Daniel Hoyer,et al.  Molecular, pharmacological and functional diversity of 5-HT receptors , 2002, Pharmacology Biochemistry and Behavior.

[24]  C. Queiroz,et al.  Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[25]  陳進明,et al.  Serotonin , 2001 .

[26]  C. Sánchez,et al.  Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors. , 1994, European journal of pharmacology.

[27]  R. Rodgers,et al.  Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol , 1994, Psychopharmacology.

[28]  D. Heal,et al.  Characterization of 8‐OH‐DPAT‐induced hypothermia in mice as a 5‐HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants , 1992, British journal of pharmacology.

[29]  H. J. Donkelaar,et al.  Cell loss in the nucleus raphes dorsalis in alzheimer's disease , 1992, Neurobiology of Aging.

[30]  H. V. Van Tol,et al.  Cloning, functional expression, and mRNA tissue distribution of the rat 5-hydroxytryptamine1A receptor gene. , 1990, The Journal of biological chemistry.

[31]  C. de Montigny,et al.  Electrophysiological Investigation of the Adaptive Response of the 5‐HT System to the Administration of 5‐HT1A Receptor Agonists , 1990, Journal of cardiovascular pharmacology.

[32]  Y. Sugimoto,et al.  The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. , 1988, European journal of pharmacology.

[33]  M. Hamon,et al.  Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[34]  G. Goodwin,et al.  The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(DI-n-propylamino)tetralin (8-OH-DPAT) A model of presynaptic 5-HT1 function , 1985, Neuropharmacology.

[35]  J. Palacios,et al.  Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.

[36]  A. Hirano,et al.  Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons , 1985, Annals of neurology.

[37]  S. Hjorth,et al.  8-HYDROXY-2-(DIPROPYLAMINO)TETRALIN, A NEW CENTRALLY ACTING 5-HYDROXYTRYPTAMINE RECEPTOR AGONIST , 1982 .

[38]  S. Hjorth,et al.  8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. , 1981, Journal of medicinal chemistry.

[39]  T. Matsuda,et al.  Potential role of serotonin1A receptors in post-weaning social isolation-induced abnormal behaviors in rodents. , 2014, Journal of pharmacological sciences.

[40]  K. Sekiguchi,et al.  Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats. , 2009, The Journal of pharmacy and pharmacology.

[41]  D. Blanchard,et al.  An ethopharmacological analysis of the behavioral effects of 8-OH-DPAT , 2005, Psychopharmacology.

[42]  S. C,et al.  Effects of the Traditional Chinese Herbal Medicine Yi-Gan San for Cholinesterase Inhibitor – Resistant Visual Hallucinations and Neuropsychiatric Symptoms in Patients With Dementia With Lewy Bodies , 2005 .

[43]  J. Evenden,et al.  Effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on locomotor activity and rearing of mice and rats , 2005, Psychopharmacology.

[44]  W. Brooks,et al.  Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation , 2004, Acta Neuropathologica.

[45]  N. Cutler,et al.  Generalised anxiety disorder: treatment options. , 2002, Drugs.

[46]  H. Baumgarten,et al.  Anatomy of central serotoninergic projection systems , 2000 .